Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …

Abstract The “metabolic syndrome”(MetS) is a clustering of components that reflect
overnutrition, sedentary lifestyles, and resultant excess adiposity. The MetS includes the …

Obesity is associated with an array of health problems in adult and pediatric populations.
Understanding the pathogenesis of obesity and its metabolic sequelae has advanced …

Aim: Adipokines are protein products of adipose tissue with paracrine and endocrine
actions, which have been implicated in the pathogenesis of cardiovascular disease. Locally …

Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …

Abstract Visfatin/extracellular-nicotinamide-phosphoribosyltranferase-(eNampt) is a
multifaceted adipokine enhanced in type-2-diabetes and obesity. Visfatin/eNampt cause in …

Visfatin has been reported as a risk factor and a potential diagnostic marker in cancer. It is
an adipokine, secreted by visceral fat and associated with the pathogenesis of arterial …

The growing worldwide burden of insulin resistance (IR) emphasizes the importance of early
identification for improved management. Obesity, particularly visceral obesity, has been a …

Human pregnancy is characterized by insulin resistance, traditionally attributed to the effects
of placental hormones. Normal pregnancy—induced insulin resistance is further enhanced …

Non-alcoholic fatty liver disease (NAFLD) is currently not a component of the diagnostic
criteria for metabolic syndrome (MetS); however, the development of NAFLD has some …